Sector valuations DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.03 CNY | -2.91% |
|
-6.00% | -14.70% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 11.53x | 2.16x | 0.56x | 0.45x | 3.62x | 5.97x | 5.99% | 2.52B | |
| 15.48x | 1.36x | 1.91x | 0.59x | 9.28x | 9.97x | -.--% | 13.38B | |
| 19.09x | 2.33x | 0.33x | 0.91x | 14.13x | 14.44x | -.--% | 6.35B | |
| 15.79x | 1.65x | 1.81x | 0.7x | 7.32x | 9.23x | 2.36% | 5.81B | |
| 11.34x | 1.71x | 0.69x | 0.71x | 5.1x | 6.68x | 3.79% | 3.21B | |
| 15.67x | 7.09x | 2.39x | 0.95x | 7.1x | 9.87x | 4.12% | 3.24B | |
| 14.4x | 4.32x | 13.72x | 1.22x | 7.42x | 14.39x | 5.74% | 3.22B | |
| 40.85x | - | 1.3x | - | - | - | - | 2.65B | |
| 23.44x | 4.1x | 1.02x | 0.67x | 8.6x | 14.08x | 1.75% | 1.72B | |
| -87.21x | 2.87x | 1.46x | 0.46x | 17.07x | 103.22x | 0.01% | 1.52B | |
| 45.52x | 5x | 1.08x | 1.33x | 15.31x | 29.33x | - | 1.03B | |
| 11.81x | 2.38x | -4.21x | 0.87x | 7.07x | 13.34x | 5.61% | 984M | |
| 10.27x | 0.73x | 0.1x | 0.23x | 2.25x | 4.64x | 4.94% | 811M | |
| 27.13x | 7.31x | 1.12x | 0.97x | 13.31x | 21.1x | 1.35% | 797M | |
| 12.95x | 1.75x | 1.07x | 0.64x | 7.8x | 12.59x | 0.4% | 633M | |
| Average | 12.54x | 3.20x | 1.62x | 0.76x | 8.96x | 19.20x | 2.77% | 3.19B | |
| Weighted average by Cap. | 14.53x | 2.58x | 2.08x | 0.74x | 9.06x | 14.29x | 1.96% |
Select your edition
All financial news and data tailored to specific country editions
